WAC 182-530-4000. Drug use review (DUR) board

In accordance with 42 C.F.R. 456.716, the medicaid agency establishes a drug use review (DUR) board. (1) The DUR board: (a) Includes health professionals who are actively practicing and licensed in the state of Washington and who have recognized knowledge and expertise in one or more of the following: (i) The clinically appropriate prescribing of outpatient drugs; (ii) The clinically appropriate dispensing and monitoring of outpatient drugs; (iii) Drug use review, evaluation, and intervention; and (iv) Medical quality assurance. (b) Is made up of at least one-third but not more than fifty-one percent physicians, and at least one-third pharmacists. (2) The agency may appoint members of the pharmacy and therapeutics committee established by the agency under chapter 182-50 WAC or other qualified individuals to serve as members of the DUR board. (3) The DUR board meets periodically to: (a) Advise the agency on drug use review activities; (b) Review provider and patient profiles; (c) Review scientific literature to establish evidence-based guidelines for the appropriate use of drugs, including the appropriate indications and dosing; (d) Recommend adoption of standards and treatment guidelines for drug therapy; (e) Recommend interventions targeted toward correcting drug therapy problems; and (f) Produce an annual report. (4) The agency has the authority to accept or reject the recommendations of the DUR board in accordance with 42 C.F.R. 456.716(c).